Novel drug development is rapidly transforming the Retinitis Pigmentosa Treatment Market, with major pharmaceutical companies and biotech innovators exploring new molecules targeting retinal preservation. Many of these drugs aim to slow photoreceptor apoptosis or enhance mitochondrial function. Early-stage results show promise in protecting existing retinal cells from further degeneration....